These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2272200)

  • 41. Modelling the response to low-frequency repetitive nerve stimulation of myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Miralles F
    Med Biol Eng Comput; 2016 Nov; 54(11):1761-1778. PubMed ID: 27016366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma exchange in hands of the neurologist.
    van der Knaap MS; Derksen RH
    Clin Neurol Neurosurg; 1986; 88(4):233-43. PubMed ID: 3542334
    [No Abstract]   [Full Text] [Related]  

  • 43. Neurologic indications for therapeutic plasma exchange: 2013 update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2014 Aug; 29(4):211-9. PubMed ID: 24890467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Therapeutic intensive plasmapheresis.
    Wenz B; Barland P
    Semin Hematol; 1981 Apr; 18(2):147-62. PubMed ID: 7013073
    [No Abstract]   [Full Text] [Related]  

  • 45. Evidence-based review of therapeutic plasma exchange in neurological disorders.
    Chhibber V; Weinstein R
    Semin Dial; 2012; 25(2):132-9. PubMed ID: 22277020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Plasma exchange in myasthenia gravis and polyradiculoneuritis].
    Gajdos P; Raphael JC
    Rev Fr Transfus Immunohematol; 1981 Dec; 24(6):657-69. PubMed ID: 7330552
    [No Abstract]   [Full Text] [Related]  

  • 47. [Intermittent myasthenic syndrome: combination of myasthenia gravis and myasthenic syndrome of the Lambert-Eaton type].
    Sanadze AG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):93-7. PubMed ID: 1664626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasmapheresis combined with lymphocytapheresis and cytotoxic drugs as a therapeutic modality in neuroimmunological diseases.
    Valbonesi M; Montani F; Florio G; Zerbi D; Beltramelli A
    Ital J Neurol Sci; 1984 Mar; 5(1):35-40. PubMed ID: 6329999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic inflammatory demyelinating polyneuropathy and paraproteinemic neuropathies.
    Glass JD; Cornblath DR
    Curr Opin Neurol; 1994 Oct; 7(5):393-7. PubMed ID: 7804458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuroimmunology: Assessing the value of plasma exchange in neurology.
    Hughes R; Hartung HP
    Nat Rev Neurol; 2011 May; 7(6):309-10. PubMed ID: 21537357
    [No Abstract]   [Full Text] [Related]  

  • 51. Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome.
    Nicolle MW
    Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1978-2005. PubMed ID: 27922503
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy and in neuropathy associated with IgM monoclonal gammopathy of unknown significance.
    Dyck PJ
    Neurology; 1990 Feb; 40(2):327-8. PubMed ID: 2300259
    [No Abstract]   [Full Text] [Related]  

  • 53. [Plasmapheresis in neurology. Critical analysis of indications and protocols].
    Seggia JC; Abreu P
    Arq Neuropsiquiatr; 1992 Sep; 50(3):324-8. PubMed ID: 1308410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Cortese I; Chaudhry V; So YT; Cantor F; Cornblath DR; Rae-Grant A
    Neurology; 2011 Jan; 76(3):294-300. PubMed ID: 21242498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
    Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
    Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic plasma exchange in neurologic disorders.
    Kes P
    Acta Med Croatica; 1997; 51(4-5):225-8. PubMed ID: 9473803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment for Lambert-Eaton myasthenic syndrome.
    Maddison P; Newsom-Davis J
    Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Plasmapheresis in patients with myasthenia gravis].
    Konishi T
    Nihon Rinsho; 2008 Jun; 66(6):1165-71. PubMed ID: 18540364
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acquired disorders of the neuromuscular junction.
    O'Neill GN
    Int Anesthesiol Clin; 2006; 44(2):107-21. PubMed ID: 16849959
    [No Abstract]   [Full Text] [Related]  

  • 60. Lambert-Eaton myasthenic syndrome with ophthalmoparesis and pseudoblepharospasm.
    Kanzato N; Motomura M; Suehara M; Arimura K
    Muscle Nerve; 1999 Dec; 22(12):1727-30. PubMed ID: 10567090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.